<DOC>
	<DOC>NCT00266526</DOC>
	<brief_summary>Specific immunotherapy with recombinant birch pollen allergen rBet v1-FV</brief_summary>
	<brief_title>Specific Immunotherapy With Recombinant Birch Pollen Allergen rBet v1-FV</brief_title>
	<detailed_description />
	<mesh_term>Rhinitis, Allergic, Seasonal</mesh_term>
	<criteria>Positive RAST result to birch pollen Positive Skin Prick Test reaction to birch pollen positive nasal provocation test result to birch pollen extract serious chronic diseases other relevant seasonal allergies</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>Allergy</keyword>
	<keyword>Birch pollen</keyword>
	<keyword>Recombinant</keyword>
</DOC>